Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Concord Medical Services Holdings

Healthcare US CCM

4.51USD
-0.32(6.63%)

Last update at 2026-06-03T20:10:00Z

Day Range

4.444.90
LowHigh

52 Week Range

3.1810.00
LowHigh

Fundamentals

  • Previous Close 4.83
  • Market Cap17.02M
  • Volume31094
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-356.78550M
  • Revenue TTM365.76M
  • Revenue Per Share TTM83.73
  • Gross Profit TTM -41.84900M
  • Diluted EPS TTM-5.5

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -669.58000M -555.59400M -839.89600M -441.65300M -441.65300M
Minority interest 343.83M 233.36M 279.33M 251.25M 3063.78M
Net income -308.24300M -297.65800M -768.99000M -404.02900M -404.02900M
Selling general administrative 404.37M 330.08M 311.16M 294.82M 294.82M
Selling and marketing expenses 48.63M 56.30M 61.48M 25.76M 25.76M
Gross profit -79.16200M -76.60800M -152.40900M 13.08M 13.08M
Reconciled depreciation 130.76M 128.45M 132.81M 104.08M 80.30M
Ebit -476.38100M -462.98500M -525.04800M -307.50100M -307.50100M
Ebitda -345.62400M -344.15600M -581.17300M -206.42900M -206.42900M
Depreciation and amortization 130.76M 118.83M -56.12500M 101.07M 101.07M
Non operating income net other - - - - -
Operating income -532.16000M -462.98500M -525.04800M -307.50100M -307.50100M
Other operating expenses 916.12M 1000.39M 997.13M 530.51M 530.51M
Interest expense 193.20M 165.67M 120.36M 81.36M 81.36M
Tax provision -17.50500M -24.57300M -70.90600M -6.56500M -37.62400M
Interest income 13.98M 10.83M 10.02M 5.89M 8.44M
Net interest income -179.21700M -154.83700M -110.33600M -67.89500M -72.91900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -17.50500M -24.57300M -70.90600M -37.62400M -37.62400M
Total revenue 383.96M 537.40M 472.08M 223.01M 223.01M
Total operating expenses 453.00M 386.38M 372.64M 320.58M 320.58M
Cost of revenue 463.12M 614.01M 624.49M 209.93M 209.93M
Total other income expense net -137.42000M -92.60900M -314.84800M -134.15200M -134.15200M
Discontinued operations - - - - -
Net income from continuing ops -652.07500M -531.02100M -768.99000M -522.67200M -404.02900M
Net income applicable to common shares -308.24300M -297.65800M -489.66100M -820.62100M -669.90900M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 6726.39M 6053.94M 6004.93M 5334.54M 5334.54M
Intangible assets 680.37M 323.29M 762.09M 522.82M 522.82M
Earning assets - - - - -
Other current assets 548.52M 445.23M 24.27M 31.41M 31.41M
Total liab 5108.64M 4306.96M 3989.28M 2933.71M 2933.71M
Total stockholder equity -2280.39000M -2121.94500M -1863.96600M -662.95500M -662.95500M
Deferred long term liab - - - - -
Other current liab 767.34M 716.34M 325.19M 243.21M 243.21M
Common stock 0.10M 0.10M 0.10M 0.10M 0.10M
Capital stock 0.10M 0.10M 0.10M 0.10M 0.10M
Retained earnings -4372.83200M -4064.58900M -3766.93100M -2456.64900M -2456.64900M
Other liab - - - 268.89M 230.06M
Good will 572.22M 575.43M 575.43M 213.66M 213.66M
Other assets 180.75M - 24.02M 250.58M 409.88M
Cash 216.22M 58.14M 158.28M 334.26M 334.26M
Cash and equivalents 216.22M - - 157.39M 334.26M
Total current liabilities 2125.36M 1951.39M 1121.24M 512.12M 512.12M
Current deferred revenue 46.15M 59.41M 100.80M 87.74M 87.74M
Net debt 3714.51M 3237.56M 3081.60M 2019.80M 2019.80M
Short term debt 1078.14M 1088.68M 548.50M 162.54M 162.54M
Short long term debt 1032.70M 1042.19M 512.58M 299.35M 148.88M
Short long term debt total 3930.73M 3295.70M 3239.88M 2354.06M 2354.06M
Other stockholder equity 2169.69M 2007.96M 1930.63M 1840.02M 1840.02M
Property plant equipment 4225.14M - 3854.04M 3764.56M 3199.16M
Total current assets 983.97M 617.21M 759.80M 676.00M 676.00M
Long term investments 472.17M 394.71M 437.87M 390.62M 313.02M
Net tangible assets - - -2793.15900M -2609.83000M -1399.43200M
Short term investments 134.62M - - 2.70M 25.05M
Net receivables 51.17M 73.50M 512.82M 280.39M 280.39M
Long term debt 2713.69M 2014.01M 2491.43M 2198.60M 1968.05M
Inventory 33.44M 40.35M 84.83M 21.61M 21.61M
Accounts payable 199.39M 129.24M 146.75M 18.63M 18.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -77.34900M -65.41900M -27.76600M -46.42900M -46.42900M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -0.00800M
Accumulated amortization - - - - -
Non currrent assets other 5.87M 16.07M 23.19M 107.47M 107.47M
Deferred long term asset charges - - - - -
Non current assets total 5742.42M 5436.73M 5245.13M 4658.54M 4658.54M
Capital lease obligations 184.34M 239.50M 235.87M 234.71M 237.14M
Long term debt total 2693.69M - - 2178.60M 1968.05M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -593.44400M -47.68100M -118.79200M -565.98100M -239.31400M
Change to liabilities - - 170.91M 69.38M 95.66M
Total cashflows from investing activities -593.44400M -47.68100M -118.79200M -565.98100M -533.88500M
Net borrowings 970.87M 19.43M 383.09M 245.53M 353.10M
Total cash from financing activities 1146.03M 257.65M 383.09M 1138.30M 1138.30M
Change to operating activities - - -14.05100M -46.93700M -79.75800M
Net income -652.07500M -297.65800M -768.99000M -404.02900M -404.02900M
Change in cash 146.56M -68.92400M 0.43M 372.09M 372.09M
Begin period cash flow 90.42M 159.34M 158.91M 74.31M 74.31M
End period cash flow 236.98M 90.42M 159.34M 446.39M 446.39M
Total cash from operating activities -397.74900M -276.47100M -216.69400M -229.76600M -229.76600M
Issuance of capital stock 510.52M 0.00000M - - -
Depreciation 130.76M 128.45M 132.81M 80.30M 80.30M
Other cashflows from investing activities -0.16000M 68.02M 237.88M -267.29200M -7.17000M
Dividends paid - - - - -
Change to inventory 6.50M 44.49M -46.75000M -14.44600M -14.44600M
Change to account receivables 12.02M 36.45M 0.64M -6.16700M -6.16700M
Sale purchase of stock 510.52M - - - -
Other cashflows from financing activities -335.35900M 194.84M 777.69M 2409.30M 2409.30M
Change to netincome - - 35.12M -145.36800M 32.54M
Capital expenditures 410.83M 115.70M 384.81M 512.90M 512.90M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -149.33300M -14.48600M 105.03M -32.61600M -32.61600M
Stock based compensation 0.00000M 0.00000M -5.91900M 20.62M 20.62M
Other non cash items 288.55M -92.78100M 392.22M 119.31M 119.31M
Free cash flow -808.58300M -392.17300M -601.50000M -742.66800M -742.66800M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CCM
Concord Medical Services Holdings		 -0.32 6.63% 4.51 - - 0.05 3.00 10.28 -0.9633
HCA
HCA Healthcare, Inc.		 -4.12 1.12% 363.23 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 -0.18 1.69% 10.50 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 0.08 1.48% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Concord Medical Services Holdings

East Zone, Hanwei Plaza, Beijing, China, 100020

Key Executives

Name Title Year Born
Dr. Jianyu Yang Chairman & CEO 1971
Mr. Boxun Zhang Chief Financial Officer 1976
Ms. Xun Liu Financial Controller NA
Mr. Wei Jiang Chief Financial Officer 1980
Mr. Boxun Zhang Chief Strategy Officer 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.